clinical decision support
HIMSS25
According to Julia Zarb, Blue x Blue CEO and founder, embracing complexity, developing strong analytical skills and understanding common sensibilities and values can help newcomers succeed in the health IT field.
HIMSS25
While the First Databank's tool already delivers EHR-based clinical decision support, it now offers more personalized guidance when lab results reveal a medication-related problem, says Virginia Halsey, the company's SVP of strategy.
HIMSS25
David Lareau, Medicomp Systems' CEO and president, says 8% to 10% of AI-captured information from complex encounters may be incorrect, but that the company's tool can flag these issues for clinicians to review.
The partners will leverage real-world evidence and AI, including the ChatRWD platform, to assist with clinical decision-making and medication formulary protocols.
Despite reluctance in the past couple of years, clinician comfort with using AI tools is growing, says Etiometry President and CEO Shane Cooke, citing results of a recent AMA survey.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.
The tech giant announced a new AI-enabled chest X-ray offering, an all-inclusive dermatology dataset, expanded partnerships and personal health LLMs for Fitbit.
The clinical support company will expand AI-driven partnership with the healthcare provider and begin rollout in 2024.
The healthcare system will translate its advanced algorithms pertaining to rapid response clinical scenarios into AvoMD's application.
The offering aims to help providers improve decision-making at the point of care while implementing generative AI effectively.